Company Announcements

RNS Number : 9820X
JPMorgan Global Growth & Income PLC
01 September 2022
 

STOCK EXCHANGE ANNOUNCEMENT

 

VOTING RIGHTS AND CAPITAL

 

JPMORGAN GLOBAL GROWTH & INCOME PLC

 ('the Company')

           

 

Legal Entity Identifier: 5493007C3I0O5PJKR078

Information disclosed in accordance with DTR 5.6.1R

 

In accordance with the FCA's Disclosure, Guidance and Transparency Rules, as at 31st August 2022, the Company's issued share capital of ordinary 5 pence shares and total voting rights are as follows:

 

Number of ordinary shares in issue:

168,559,285

Number of ordinary shares held in treasury (non-voting):

0

Total Voting Rights:

168,559,285

 

 

Therefore, the above total voting rights figure (168,559,285) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

Note, the above figures do not include the new shares that were issued pursuant to the combination of assets of The Scottish Investment Trust PLC with the Company, as announced on 31 August 2022 (RNS Number: 8126X), and were admitted to trading at 8.00 a.m. on 1 September 2022.

 

 

 

1st September 2022

 

For further information, please contact:

 

 

Divya Amin

For and on behalf of

JPMorgan Funds Limited - Company Secretary

020 7742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFLFELAVILIIF